Metabolic syndrome is linked to chromosome 7q21 and associated with genetic variants in CD36 and GNAT3 in Mexican Americans

Obesity

Volumn 20, Issue 10, 2012, Pages 2083-2092

  Farook, Vidya S ^a   Puppala, Sobha ^a   Schneider, Jennifer ^a   Fowler, Sharon P ^b   Chittoor, Geetha ^a   Dyer, Thomas D ^a   Allayee, Hooman ^c   Cole, Shelley A ^a   Arya, Rector ^b   Black, Mary H ^c   Curran, Joanne E ^a   Almasy, Laura ^a   Buchanan, Thomas A ^c   Jenkinson, Christopher P ^b   Lehman, Donna M ^b   Watanabe, Richard M ^c   Blangero, John ^a   Duggirala, Ravindranath ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN;

ADULT; ARTICLE; CD36 GENE; CHROMOSOME 7Q; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GNAT3 GENE; HISPANIC; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MOLECULAR PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANTIGENS, CD36; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; LOD SCORE; MALE; METABOLIC SYNDROME X; MEXICAN AMERICANS; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; UNITED STATES;

EID: 84866735440     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.74     Document Type: Article

References (40)

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
2. Johnson WD, Kroon JJ, Greenway FL et al. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med 2009;163:371-377.
3. NCEP/ATPIII Expert panel on detection, evaluation and treatment of High Blood Cholesterol in adults. Executive summary of the Third report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High blood cholesterol in adults (ATP III). JAMA 2001;285:2486-2497.
4. Grundy SM, Cleeman JI, Daniels SR et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
5. Simmons RK, Alberti KG, Gale EA et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010;53:600-605.
6. Duggirala R, Blangero J, Almasy L et al. A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. Am J Hum Genet 2001;68:1149-1164.
7. Arya R, Blangero J, Williams K et al. Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic mexican-americans. Diabetes 2002;51:841-847.
8. Terán-García M, Bouchard C. Genetics of the metabolic syndrome. Appl Physiol Nutr Metab 2007;32:89-114.
9. Kraja AT, Vaidya D, Pankow JS et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes 2011;60:1329-1339.
10. Langefeld CD, Wagenknecht LE, Rotter JI et al.; Insulin Resistance Atherosclerosis Study Family Study. Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. Diabetes 2004;53:1170-1174.
11. Ng MC, So WY, Lam VK et al. Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes 2004;53:2676-2683.
12. Puppala S, Dodd GD, Fowler S et al. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 2006;78:377-392.
13. Genuth S, Alberti KG, Bennett P et al.; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
14. Noushmehr H, D'Amico E, Farilla L et al. Fatty acid translocase (FAT/CD36) is localized on insulin-containing granules in human pancreatic beta-cells and mediates fatty acid effects on insulin secretion. Diabetes 2005;54:472-481.
15. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-247.
16. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 1996;58:1323-1337.
17. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-1211.
18. Blangero J, Goring HH, Kent JW Jr et al. Quantitative trait nucleotide analysis using Bayesian model selection. Hum Biol 2005;77:541-559.
19. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 2005;95:221-227.
20. Tenenbaum A, Fisman EZ. "The metabolic syndrome. is dead": these reports are an exaggeration. Cardiovasc Diabetol 2011;10:11.
21. Henneman P, Aulchenko YS, Frants RR et al. Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study. J Med Genet 2008;45:572-577.
22. Sung J, Lee K, Song YM. Heritabilities of the metabolic syndrome phenotypes and related factors in Korean twins. J Clin Endocrinol Metab 2009;94:4946-4952.
23. Andersen M, Lenhard B, Whatling C, Eriksson P, Odeberg J. Alternative promoter usage of the membrane glycoprotein CD36. BMC Mol Biol 2006;7:8.
24. Yang Z, Ming X F. CD36: the common soil for inflammation in obesity and atherosclerosis? Cardiovasc Res 2011;89:485-486.
25. Aitman TJ, Glazier AM, Wallace CA et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999;21:76-83.
26. Pravenec M, Landa V, Zidek V et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 2001;27:156-158.
27. Miyaoka K, Kuwasako T, Hirano K et al. CD36 deficiency associated with insulin resistance. Lancet 2001;357:686-687.
28. Love-Gregory L, Sherva R, Sun L et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet 2008;17:1695-1704.
29. Love-Gregory L, Sherva R, Schappe T et al. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum Mol Genet 2011;20:193-201.
30. Noel SE, Lai CQ, Mattei J et al. Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults. Atherosclerosis 2010;211:210-215.
31. Ma X, Bacci S, Mlynarski W et al. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet 2004;13:2197-2205.
32. Banerjee M, Gautam S, Saxena M, Bid HM, Agrawal CG. Association of CD36 gene variants rs1761667 (G 〉 A) and rs1527483 (C 〉 T) with Type 2 diabetes in North Indian population. In J Diabetes Mellitus 2010;2:179-183.
33. Garcia-Bailo B, Toguri C, Eny KM, El-Sohemy A. Genetic variation in taste and its influence on food selection. OMICS 2009;13:69-80.
34. Fushan AA, Simons CT, Slack JP, Drayna D. Association between common variation in genes encoding sweet taste signaling components and human sucrose perception. Chem Senses 2010;35:579-592.
35. Laugerette F, Passilly-Degrace P, Patris B et al. CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions. J Clin Invest 2005;115:3177-3184.
36. Toguri, C. Genetic Variation in CD36 and Dietary Fat Intake. M.Sc. Dissertation, University of Toronto, 2008, MR45176.
37. Jang HJ, Kokrashvili Z, Theodorakis MJ et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA 2007;104:15069-15074.
38. Steinert RE, Gerspach AC, Gutmann H et al. The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). Clin Nutr 2011;30:524-532.
39. Yamaoka-Tojo M, Tojo T, Takahira N et al. Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Cardiovasc Diabetol 2010;9:17.
40. Watanabe RM, Allayee H, Xiang AH et al. Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. Diabetes 2007;56:1481-1485.